AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Macsita-MXR 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Macsita-MXR 50/500 Tablet

Diabex-Duo 50/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like vision loss and kidney disease, potentially lowering the risk of stroke or heart attack. Diabex-Duo may be used independently or in conjunction with other diabetes treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual health, blood sugar readings, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; cessation requires physician approval. Adherence to the prescribed diet and exercise plan is crucial for diabetes control, as lifestyle significantly impacts management. Common side effects include nausea, vomiting, diarrhea, headache, stomach discomfort, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, especially when combined with insulin or sulfonylureas; learn its symptoms and management. This medication isn't for everyone. Inform your doctor of any history of liver, kidney, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or breastfeeding individuals should consult their doctor. Interactions with other medications are possible; disclose all medications to your doctor for safety. Alcohol should be limited due to its blood sugar-lowering effect. Your physician will monitor kidney function and blood glucose levels throughout treatment.

Uses of Macsita-MXR 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Macsita-MXR 50/500 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Macsita-MXR 50/500 with a meal.

Common Side effects of Macsita-MXR 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Macsita-MXR 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Macsita-MXR 50/500 Tablets should be administered with a meal.

How Macsita-MXR 50/500 Tablet works:

Macsita-MXR 50/500 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and augments insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Macsita-MXR 50/500 Tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Macsita-MXR 50/500 tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Macsita-MXR 50/500 tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Macsita-MXR 50/500 Tablets cautiously, potentially requiring dose modification. Consult your physician. Macsita-MXR 50/500 Tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Macsita-MXR 50/500 tablets is likely contraindicated in individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Macsita-MXR 50/500 Tablet :

Should you forget to take your Macsita-MXR 50/500 Tablet, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Macsita-MXR 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Macsita-MXR 50/500 Tablet

Macsita-MXR 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Macsita-MXR 50/500 Tablet can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency can cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, potentially affecting mental state. To mitigate these risks, supplemental vitamin B12 is recommended at least annually by some researchers.
Macsita-MXR 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Macsita-MXR 50/500 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-MXR 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Macsita-MXR 50/500 (containing metformin) can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Macsita-MXR 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Macsita-MXR 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infection. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Macsita-MXR 50/500 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-MXR 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Macsita-MXR 50/500 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Macsita-MXR 50/500 Tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Macsita-MXR 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Macsita-MXR 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Macsita-MXR 50/500 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-MXR 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Macsita-MXR 50/500 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Macsita-MXR 50/500 Tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency may cause anemia, neurological issues (including tingling, numbness in extremities, weakness, and ataxia), and urinary problems, potentially affecting mental state. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Macsita-MXR 50/500 Tablet
124